How Well Does The Partin Nomogram Predict Pathological Stage After Radical Prostatectomy In A Community Based Population? Results Of The Cancer Of The Prostate Strategic Urological Research Endeavor

The Partin nomogram uses preoperative Gleason grade, serum prostate specific antigen and clinical stage to predict pathological outcome after radical prostatectomy. It was developed and validated in a select population of patients at 3 academic institutions. Although the nomogram is widely used, it has yet to be validated in a community based population. We assessed the performance of the nomogram in the Cancer of the Prostate Strategic Urological Research Endeavor, a nationwide, community based observational disease registry of men with prostate cancer.